Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis
Open Access
- 1 May 2012
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (9) , 3349-3353
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agentsTuberculosis, 2011
- Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agentsProceedings of the National Academy of Sciences, 2010
- Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidinesEuropean Journal of Medicinal Chemistry, 2009
- Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitorsBioorganic & Medicinal Chemistry Letters, 2009
- Anti-mycobacterial activity of a bis-sulfonamideBioorganic & Medicinal Chemistry Letters, 2007
- Serine threonine protein kinases of mycobacterial genus: phylogeny to functionPhysiological Genomics, 2007
- The Ser/Thr Protein Kinase PknB Is Essential for Sustaining Mycobacterial GrowthJournal of Bacteriology, 2006
- The structure of PknB in complex with mitoxantrone, an ATP‐competitive inhibitor, suggests a mode of protein kinase regulation in mycobacteriaFEBS Letters, 2006
- Proteomic Identification of M.tuberculosis Protein Kinase Substrates: PknB Recruits GarA, a FHA Domain-containing Protein, Through Activation Loop-mediated InteractionsJournal of Molecular Biology, 2005
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998